Top

Published in:

01-12-2015 | Neurology and Preclinical Neurological Studies - Original Article

Vitamin D deficiency and its relationship with endothelial dysfunction in patients with early Parkinson’s disease

Authors: Jung Han Yoon, Dong Kyu Park, Seok Woo Yong, Ji Man Hong

Published in: Journal of Neural Transmission | Issue 12/2015

Abstract

Increasing evidence has shown that individuals with Parkinson’s disease (PD) have lower levels of 25-hydroxyvitamin D (25[OH]D) than healthy controls. Low vitamin D has been associated with endothelial dysfunction which may play a role in the pathogenesis and progression of PD. Flow-mediated dilation (FMD) is widely used as a clinical marker of overall endothelial function. We evaluated the relationship between serum 25(OH)D levels and FMD in PD. We enrolled 81 patients with early PD and 52 healthy controls, and we evaluate endothelial function based on vitamin D status and identify the association between FMD and vitamin D status in patients with early PD. The mean serum 25(OH)D levels were significantly lower in the PD patients than in the controls (21.8 ± 9.5 vs. 25.2 ± 9.3 ng/mL, p < 0.05). FMD was significantly lower in the PD patients (7.1 ± 1.8 %) than in the controls (8.1 ± 2.1 %, p < 0.05). The serum 25(OH)D was significantly associated with FMD independently of age, cardiovascular disease risk factors, body mass index, motor Unified PD Rating Scale status and homocysteine levels (adjusted R ² = 0.331, β = 0.494, p < 0.001). These findings provide evidence of a possible association between endothelial dysfunction as assessed by FMD and low vitamin D status in patients with early PD.

Afzal S, Bojesen SE, Nordestgaard BG (2014) Reduced 25-hydroxyvitamin D and risk of Alzheimer’s disease and vascular dementia. Alzheimer’s Dement J Alzheimer’s Assoc 10(3):296–302. doi:10.1016/j.jalz.2013.05.1765 CrossRef

Al Mheid I, Patel R, Murrow J, Morris A, Rahman A, Fike L, Kavtaradze N, Uphoff I, Hooper C, Tangpricha V, Alexander RW, Brigham K, Quyyumi AA (2011) Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. J Am Coll Cardiol 58(2):186–192. doi:10.1016/j.jacc.2011.02.051 PubMedCentralCrossRefPubMed

Cai H, Harrison DG (2000) Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87(10):840–844CrossRefPubMed

Chitalia N, Recio-Mayoral A, Kaski JC, Banerjee D (2012) Vitamin D deficiency and endothelial dysfunction in non-dialysis chronic kidney disease patients. Atherosclerosis 220(1):265–268. doi:10.1016/j.atherosclerosis.2011.10.023 CrossRefPubMed

Chitalia N, Ismail T, Tooth L, Boa F, Hampson G, Goldsmith D, Kaski JC, Banerjee D (2014) Impact of vitamin D supplementation on arterial vasomotion, stiffness and endothelial biomarkers in chronic kidney disease patients. PLoS One 9(3):e91363. doi:10.1371/journal.pone.0091363 PubMedCentralCrossRefPubMed

Codoner-Franch P, Tavarez-Alonso S, Simo-Jorda R, Laporta-Martin P, Carratala-Calvo A, Alonso-Iglesias E (2012) Vitamin D status is linked to biomarkers of oxidative stress, inflammation, and endothelial activation in obese children. J Pediatr 161(5):848–854. doi:10.1016/j.jpeds.2012.04.046 CrossRefPubMed

Cook RD (1979) Influential observations in linear regression. J Am Stat Assoc 74(365):169–174. doi:10.1080/01621459.1979.10481634 CrossRef

Dede DS, Yavuz B, Yavuz BB, Cankurtaran M, Halil M, Ulger Z, Cankurtaran ES, Aytemir K, Kabakci G, Ariogul S (2007) Assessment of endothelial function in Alzheimer’s disease: is Alzheimer’s disease a vascular disease? J Am Geriatr Soc 55(10):1613–1617. doi:10.1111/j.1532-5415.2007.01378.x CrossRefPubMed

Ding H, Dhima K, Lockhart KC, Locascio JJ, Hoesing AN, Duong K, Trisini-Lipsanopoulos A, Hayes MT, Sohur US, Wills AM, Mollenhauer B, Flaherty AW, Hung AY, Mejia N, Khurana V, Gomperts SN, Selkoe DJ, Schwarzschild MA, Schlossmacher MG, Hyman BT, Sudarsky LR, Growdon JH, Scherzer CR (2013) Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study. Neurology 81(17):1531–1537. doi:10.1212/WNL.0b013e3182a95818 PubMedCentralCrossRefPubMed

Evatt ML, Delong MR, Khazai N, Rosen A, Triche S, Tangpricha V (2008) Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease. Arch Neurol 65(10):1348–1352. doi:10.1001/archneur.65.10.1348 PubMedCentralCrossRefPubMed

Evatt ML, DeLong MR, Kumari M, Auinger P, McDermott MP, Tangpricha V (2011) High prevalence of hypovitaminosis D status in patients with early Parkinson disease. Arch Neurol 68(3):314–319. doi:10.1001/archneurol.2011.30 CrossRefPubMed

Farid K, Volpe-Gillot L, Petras S, Plou C, Caillat-Vigneron N, Blacher J (2012) Correlation between serum 25-hydroxyvitamin D concentrations and regional cerebral blood flow in degenerative dementia. Nucl Med Commun 33(10):1048–1052. doi:10.1097/MNM.0b013e32835674c4 CrossRefPubMed

Freeman LR, Keller JN (2012) Oxidative stress and cerebral endothelial cells: regulation of the blood-brain-barrier and antioxidant based interventions. Biochim Biophys Acta 1822(5):822–829. doi:10.1016/j.bbadis.2011.12.009 PubMedCentralCrossRefPubMed

Gonzales MM, Tarumi T, Tanaka H, Sugawara J, Swann-Sternberg T, Goudarzi K, Haley AP (2010) Functional imaging of working memory and peripheral endothelial function in middle-aged adults. Brain Cogn 73(2):146–151. doi:10.1016/j.bandc.2010.04.007 PubMedCentralCrossRefPubMed

Grammas P, Martinez J, Miller B (2011) Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases. Expert Rev Mol Med 13:e19. doi:10.1017/s1462399411001918 CrossRefPubMed

Gurses KM, Tokgozoglu L, Yalcin MU, Kocyigit D, Dural M, Canpinar H, Yorgun H, Sahiner ML, Kaya EB, Akin S, Gurlek A, Guc D, Aytemir K (2014) Markers of subclinical atherosclerosis in premenopausal women with vitamin D deficiency and effect of vitamin D replacement. Atherosclerosis 237(2):784–789. doi:10.1016/j.atherosclerosis.2014.10.096 CrossRefPubMed

Hoth KF, Tate DF, Poppas A, Forman DE, Gunstad J, Moser DJ, Paul RH, Jefferson AL, Haley AP, Cohen RA (2007) Endothelial function and white matter hyperintensities in older adults with cardiovascular disease. Stroke J Cereb Circ 38(2):308–312. doi:10.1161/01.STR.0000254517.04275.3f CrossRef

Jablonski KL, Chonchol M, Pierce GL, Walker AE, Seals DR (2011) 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension 57(1):63–69. doi:10.1161/HYPERTENSIONAHA.110.160929 PubMedCentralCrossRefPubMed

Jang W, Park J, Kim JS, Youn J, Oh E, Kwon KY, Jo KD, Lee MK, Kim HT (2015) Vitamin D deficiency in Parkinson’s disease patients with orthostatic hypotension. Acta Neurol Scand. doi:10.1111/ane.12390 PubMed

Jenner P (2003) Oxidative stress in Parkinson’s disease. Ann Neurol 53(Suppl 3):S26–S36. doi:10.1002/ana.10483 (discussion S36-28) CrossRefPubMed

Knekt P, Kilkkinen A, Rissanen H, Marniemi J, Saaksjarvi K, Heliovaara M (2010) Serum vitamin D and the risk of Parkinson disease. Arch Neurol 67(7):808–811. doi:10.1001/archneurol.2010.120 PubMedCentralCrossRefPubMed

Kulie T, Groff A, Redmer J, Hounshell J, Schrager S (2009) Vitamin D: an evidence-based review. J Am Board Fam Med JABFM 22(6):698–706. doi:10.3122/jabfm.2009.06.090037 CrossRefPubMed

Littlejohns TJ, Henley WE, Lang IA, Annweiler C, Beauchet O, Chaves PH, Fried L, Kestenbaum BR, Kuller LH, Langa KM, Lopez OL, Kos K, Soni M, Llewellyn DJ (2014) Vitamin D and the risk of dementia and Alzheimer disease. Neurology 83(10):920–928. doi:10.1212/wnl.0000000000000755 PubMedCentralCrossRefPubMed

Liu Y, Zhang BS (2014) Serum 25-hydroxyvitamin D predicts severity in Parkinson’s disease patients. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol 35(1):67–71. doi:10.1007/s10072-013-1539-x

Mehanna R, Scherzer CR, Ding H, Locascio JJ (2014) Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker study. Neurology 82(18):1666. doi:10.1212/01.wnl.0000449750.81263.7d (discussion 1666) CrossRefPubMed

Newmark HL, Newmark J (2007) Vitamin D and Parkinson’s disease—a hypothesis. Move Disord Off J Move Disord Soc 22(4):461–468. doi:10.1002/mds.21317 CrossRef

Peterson AL, Mancini M, Horak FB (2013a) The relationship between balance control and vitamin D in Parkinson’s disease—a pilot study. Move Disord Off J Move Disord Soc 28(8):1133–1137. doi:10.1002/mds.25405 CrossRef

Peterson AL, Murchison C, Zabetian C, Leverenz JB, Watson GS, Montine T, Carney N, Bowman GL, Edwards K, Quinn JF (2013b) Memory, mood, and vitamin D in persons with Parkinson’s disease. J Parkinson’s Dis 3(4):547–555. doi:10.3233/JPD-130206

Price JM, Sutton ET, Hellermann A, Thomas T (1997) beta-Amyloid induces cerebrovascular endothelial dysfunction in the rat brain. Neurol Res 19(5):534–538PubMed

Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K (2005) Abnormal bone and calcium metabolism in immobilized Parkinson’s disease patients. Move Disord Off J Move Disord Soc 20(12):1598–1603. doi:10.1002/mds.20658 CrossRef

Sato Y, Honda Y, Iwamoto J (2007) Risedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson disease. Neurology 68(12):911–915. doi:10.1212/01.wnl.0000257089.50476.92 CrossRefPubMed

Suzuki M, Yoshioka M, Hashimoto M, Murakami M, Kawasaki K, Noya M, Takahashi D, Urashima M (2012) 25-Hydroxyvitamin D, vitamin D receptor gene polymorphisms, and severity of Parkinson’s disease. Move Disord Off J Move Disord Soc 27(2):264–271. doi:10.1002/mds.24016 CrossRef

Suzuki M, Yoshioka M, Hashimoto M, Murakami M, Noya M, Takahashi D, Urashima M (2013) Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease. Am J Clin Nutr 97(5):1004–1013. doi:10.3945/ajcn.112.051664 CrossRefPubMed

Toffanello ED, Coin A, Perissinotto E, Zambon S, Sarti S, Veronese N, De Rui M, Bolzetta F, Corti MC, Crepaldi G, Manzato E, Sergi G (2014) Vitamin D deficiency predicts cognitive decline in older men and women: The Pro.V.A. Study. Neurology 83(24):2292–2298. doi:10.1212/wnl.0000000000001080 CrossRefPubMed

Uberti F, Lattuada D, Morsanuto V, Nava U, Bolis G, Vacca G, Squarzanti DF, Cisari C, Molinari C (2014) Vitamin D protects human endothelial cells from oxidative stress through the autophagic and survival pathways. J Clin Endocrinol Metab 99(4):1367–1374. doi:10.1210/jc.2013-2103 CrossRefPubMed

van den Bos F, Speelman AD, van Nimwegen M, van der Schouw YT, Backx FJ, Bloem BR, Munneke M, Verhaar HJ (2013) Bone mineral density and vitamin D status in Parkinson’s disease patients. J Neurol 260(3):754–760. doi:10.1007/s00415-012-6697-x CrossRefPubMed

Vita JA, Keaney JF Jr (2002) Endothelial function: a barometer for cardiovascular risk? Circulation 106(6):640–642CrossRefPubMed

Wang L, Evatt ML, Maldonado LG, Perry WR, Ritchie JC, Beecham GW, Martin ER, Haines JL, Pericak-Vance MA, Vance JM, Scott WK (2015) Vitamin D from different sources is inversely associated with Parkinson disease. Move Disord Off J Move Disord Soc 30(4):560–566. doi:10.1002/mds.26117 CrossRef

White RP, Deane C, Vallance P, Markus HS (1998) Nitric oxide synthase inhibition in humans reduces cerebral blood flow but not the hyperemic response to hypercapnia. Stroke J Cereb Circ 29(2):467–472CrossRef

White RP, Vallance P, Markus HS (2000) Effect of inhibition of nitric oxide synthase on dynamic cerebral autoregulation in humans. Clin Sci 99(6):555–560CrossRefPubMed

Yiu YF, Chan YH, Yiu KH, Siu CW, Li SW, Wong LY, Lee SW, Tam S, Wong EW, Cheung BM, Tse HF (2011) Vitamin D deficiency is associated with depletion of circulating endothelial progenitor cells and endothelial dysfunction in patients with type 2 diabetes. J Clin Endocrinol Metab 96(5):E830–E835. doi:10.1210/jc.2010-2212 CrossRefPubMed

Yoon JH, Lee JS, Yong SW, Hong JM, Lee PH (2014) Endothelial dysfunction and hyperhomocysteinemia in Parkinson’s disease: flow-mediated dilation study. Move Disord Off J Move Disord Soc 29(12):1551–1555. doi:10.1002/mds.26005 CrossRef

Zlokovic BV (2011) Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders. Nat Rev Neurosci 12(12):723–738. doi:10.1038/nrn3114 PubMedCentralPubMed

Title: Vitamin D deficiency and its relationship with endothelial dysfunction in patients with early Parkinson’s disease
Authors: Jung Han Yoon
Dong Kyu Park
Seok Woo Yong
Ji Man Hong
Publication date: 01-12-2015
Publisher: Springer Vienna
Published in: Journal of Neural Transmission / Issue 12/2015
Print ISSN: 0300-9564
Electronic ISSN: 1435-1463
DOI: https://doi.org/10.1007/s00702-015-1452-y

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Vitamin D deficiency and its relationship with endothelial dysfunction in patients with early Parkinson’s disease

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 12/2015

Quantitative assessment of non-motor fluctuations in Parkinson’s disease using the Non-Motor Symptoms Scale (NMSS)

Erratum to: Is cognitive stability in Parkinson’s disease a predictable phenomenon? A 5-year follow-up study

Generalized motor inhibitory deficit in Parkinson’s disease patients who freeze

Small intestine dysfunction in Parkinson’s disease

Diverse effects of Brilliant Blue G administration in models of trigeminal activation in the rat

Is cognitive stability in Parkinson’s disease a predictable phenomenon? A 5-year follow-up study